Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- 1 February 1994
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 61 (2) , 281-287
- https://doi.org/10.1016/s0015-0282(16)56518-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilismPublished by Elsevier ,2003
- Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostateMolecular and Cellular Endocrinology, 1990
- Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in cultureThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive shionogi tumor in miceJournal of Steroid Biochemistry, 1988
- Tolerance of spironolactoneBritish Journal of Dermatology, 1988
- Analysis of the androgenic activity of synthetic “progestins” currently used for the treatment of prostate cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- 10 Treatment of hirsutism with spironolactoneClinics in Endocrinology and Metabolism, 1986
- Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetateMolecular and Cellular Endocrinology, 1985
- Antiandrogenic properties of spironolactone. Clinical trial in the management of female hirsutismJournal of Endocrinological Investigation, 1983
- ORAL PROGESTATIONAL ACTIVITY OF SPIRONOLACTONE1Journal of Clinical Endocrinology & Metabolism, 1978